Home › Clinical Cases
New advances in intravitreal treatment and monitoring promise to improve the management of many sight-threatening retinal diseases. A wide array of imaging techniques has recently become available,… More >>
Sub-analysis of pinnacle trials utilizing anti–vascular endothelial growth factor (VEGF) therapies for the treatment of diabetic macular edema (DME) has demonstrated the efficacy of these… More >>
The utilization of anti–vascular endothelial growth factor (VEGF) therapies in treatment protocols for neovascular retinal disorders has led to significant visual gains and long-term management of… More >>
Pinnacle clinical trials evaluating anti–vascular endothelial growth factor (VEGF) therapies in management protocols for neovascular age-related macular degeneration (nAMD) have demonstrated… More >>
The continued refinement of treatment protocols for the management of retinal diseases provides the potential to enhance visual acuity outcomes, reduce treatment burden, and improve patient… More >>
Anti-vascular endothelial growth factor (anti-VEGF) therapy has become standard of care for many retinal diseases, such as neovascular age-related macular degeneration and diabetic retinopathy… More >>